PrimeC 748 mg
NST-PK-003
Phase 1 small_molecule completed
Quick answer
PrimeC 748 mg for Pharmacokinetics is a Phase 1 program (small_molecule) at NeuroSense Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- NeuroSense Therapeutics
- Indication
- Pharmacokinetics
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed